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Introduction: Short-echo-time (TE) proton spectroscopic imaging is capable not only to map the spatial distribution of NAA, creatine, choline, 
glutamate/glutamine and myo-inositol but also of metabolites having lower concentrations and/or giving more complex spectral patterns. Glucose 
(Glc) and lactate (Lac) are compounds which are closely related to energy production in the brain tissue. The spatial distribution of these compounds 
in brain with microliter resolution (1) can provide information about the function of various brain structures or about brain tumor metabolism (2). 
The aim of this study was to test the feasibility of measuring distribution of Glc and Lac in the brain of a healthy rat at different plasma Glc levels 
using short-TE spectroscopic imaging.  
Experimental: The data were obtained from brain of two adult Sprague-Dawley rats. For inducing hyperglycemia, 20 % Glc solution was infused 
into the femoral vein at a rate of 0.8 – 2 mL/hour. Plasma Glc levels were measured using an Analox GM7 analyzer (Analox Instruments, MA, USA) 
and were increased from 6.4 mmol/L (normoglycemia) to 15.0 mmol/L. Metabolic maps were obtained on an actively shielded 9.4 T/31 cm 
spectrometer (Varian/Magnex Scientific) using 
a SPECIAL spectroscopy sequence (TR/TE = 
2000/2.8 ms) with phase encoding in the 
horizontal plane (1). A home-built 14 mm 
diameter quadrature coil was used as a 
transceiver. Field homogeneity was adjusted 
by FASTMAP (3). The size of the excited VOI 
was 9×2×10 mm3. Two acquisitions were 
collected for each of the 32×32 phase encoding 
steps using FOV of 24 mm×24 mm, giving a 
nominal voxel size of 0.75×0.75×2 mm3 (1.1 
μL). The k-space data were then filtered with 
an optimized Hanning function in two spatial 
domains, thus giving the effective spatial 
resolution of 1.7 μL (1). Absolute 
concentrations of metabolites were calculated from the spectra of individual 
voxels using LCModel (4). Reference water signals were measured using the 
same protocol without water suppression and with TR=1.5 s. The total 
measurement time, including both metabolite and water scans, was 2 hours.  
Results: Fig. 1 shows a VOI, which was phase encoded into 10×12 voxels 
(Fig. 2). The VOI included mostly hippocampi, striatum and frontal cortex. 
Total creatine (Cr) was used as an indicator of the measurement stability. Its 
mean concentration (7.7 – 7.8 mmol/kg) did not change at different plasma Glc 
concentrations and its distribution was also very stable, with higher levels in 
hippocampus and cortex than in striatum. With increasing plasma Glc level to 
11.1 mmol/L, the mean Glc concentration remained almost the same (from 2.7 
to 2.6 mmol/kg) whereas the Lac concentration increased from 1.7 to 2.3 
mmol/kg. With further increasing plasma Glc to 15.0 mml/L, the brain Glc 
concentration raised to 4.8 mmol/kg, whereas Lac slightly dropped to 2.1 
mmol/kg. The mean brain Glc concentrations at different plasma Glc levels fell 
in the range found by 13C spectroscopy (5). The spatial distribution of Glc and 
Lac did not vary substantially with Glc infusion: Glc seemed to be highest in 
cortex, Lac was higher in striatum and hippocampus than in cortex. 
Discussion and Conclusions: The stable concentration of total creatine suggests an absence of systematic biases during the experiment. Relatively 
small changes in metabolite concentrations can be clearly seen in their maps. The observed differences in various brain regions agree well with those 
obtained by single voxel spectroscopy (6). This preliminary study indicates that short-TE proton spectroscopic imaging can be used to measure the 
spatial distribution of low-concentration metabolites or those with complicated spectral patterns in rat brain with a resolution comparable to PET. 
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Fig. 1. Position of the VOI 
in the rat brain 
Fig. 2. Metabolic maps of Cr, Glc and Lac in the brain region 
depicted in Fig.1 at Glc plasma concentrations of 6.4 (a), 11.1 
(b) and 15.0 (c) mmol/L. The  numbers on the color scales 
denote absolute brain concentrations in mmol/kg of tissue. 
Spectra from the outermost voxels were potentially affected by 
chemical shift displacement errors of the excitation scheme.  
